Accuracy of monitors used for blood pressure checks in English retail pharmacies: A cross-sectional observational study

British Journal of General Practice

Volumn 66, Issue 646, 2016, Pages e309-e314

  Hodgkinson, James ^a   Koshiaris, Constantinos ^b   Martin, Una ^a   Mant, Jonathan ^c   Heneghan, Carl ^b   Richard Hobbs, F D ^b   McManus, Richard J ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Blood pressure monitors; Calibration; Community pharmacy services; Hypertension; Primary health care

Indexed keywords

ARTICLE; BLOOD PRESSURE CUFF; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITOR; BLOOD PRESSURE MONITORING; CALIBRATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENGLAND; GENERAL PRACTICE; HUMAN; HYPERTENSION; MEASUREMENT ACCURACY; OBSERVATIONAL STUDY; PHARMACY; PRIMARY HEALTH CARE; SPHYGMOMANOMETER; BLOOD PRESSURE; DEVICES; EPIDEMIOLOGY; FEMALE; MALE; PHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; UTILIZATION;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CALIBRATION; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HUMANS; HYPERTENSION; MALE; PHARMACIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPHYGMOMANOMETERS;

EID: 84969218950     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp16X684769     Document Type: Article

References (40)

1. Prospective Studies Collaboration. Age-specific relevance of usual BP to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-1913.
2. Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360(9343): 1347-1360.
3. O'Brien E, Petrie J, Littler W, et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11(6): 677-679.
4. Association for the Advancement of Medical Instrumentation. American National Standard. Electronic or automated sphygmomanometers ANSI/AAMI SP10-1992. Arlington, VA: AAMI, 1993.
5. O'Brien E, Atkins N, Stergiou G, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010; 15(1): 23-38.
6. Department of Health. Investing in general practice: the new general medical services contract. 2003. http://webarchive.nationalarchives.gov. uk/20130107105354/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4071966 (accessed 16 Mar 2016).
7. Health and Social Care Information Centre. Health Survey for England 2012. Trend tables. 2013. http://www.hscic.gov.uk/catalogue/PUB13219 (accessed 16 Mar 2016).
8. Bankart MJ, Anwar MS, Walker N, et al. Are there enough GPs in England to detect hypertension and maintain access? A cross-sectional study. Br J Gen Pract 2013; DOI: 10.3399/bjgp13X667204.
9. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med 2003; 25(2): 144-153.
10. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41(11): 1770-1781.
11. Chan AHW, Campbell NR, Lewanczuk RZ, et al. 2008 Canadian Hypertension Education Program Guidelines for the management of hypertension by pharmacists. Can Pharm J 2008; 141(6): 327-331.
12. McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus. Arch Intern Med 2008; 168(21): 2355-2361.
13. Jones C, Simpson SH, Mitchell D, et al. Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program [A-CHAMP). Can J Cardiol 2008; 24(7): 561-567.
14. Mangum S, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy based hypertension and stroke prevention screening projects. J Am Pharm Assoc 2003; 43(1): 50-55.
15. Earle KA, Taylor P, Wyatt S, et al. A physician-pharmacist model for the surveillance of blood pressure in the community: a feasibility study. J Hum Hypertens 2001; 15(8): 529-533.
16. Pongwecharak J, Treeranurat T. Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy. Pharm World Sci 2010; 32(3): 329-333.
17. Sabater-Hernandez D, de la Sierra A, Bellver-Monzo O, et al. Guidelines for community pharmacists in patients with arterial hypertension and cardiovascular risk. Consensus document (extended version). Ars Pharm 2011; 52(2): 38-58.
18. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328(7440): 634-640.
19. Viera AJ, Cohen LW, Mitchell CM, Sloane PD. Hypertensive patients' use of blood pressure monitors stationed in pharmacies and other locations: a cross-sectional mail survey. BMC Health Serv Res 2008; 8: 216.
20. Blood Pressure UK. Know Your Numbers! week 2013 evaluation report. Blood Pressure Association. http://www.bloodpressureuk.org/microsites/kyn/Home/AboutKYN/KYN2013 (accessed 16 Mar 2016).
21. Whitcomb BL, Prochazka A, LoVerde M, Byyny RL. Failure of the community-based Vita-Stat automated blood pressure device to accurately measure blood pressure. Arch Fam Med 1995; 4(5): 419-424.
22. Lewis JE, Boyle E, Magharious L, Myers MG. Evaluation of a community-based automated blood pressure measuring device. CMAJ 2002; 166(9): 1145-1148.
23. Van Durme DJ, Goldstein M, Pal N, et al. The accuracy of community-based automated blood pressure machines. J Fam Pract 2000; 49(5): 449-452.
24. Salaita K, Whelton PK, Seidler AJ. A community-based evaluation of the Vita-Stat automatic blood pressure recorder. Am J Hypertens 1990; 3(5 Pt 1): 366-372.
25. Graves JW. Blood pressure measurement in public places. Am Fam Physician 2005; 71(5): 851-852.
26. Ross KL, Bhasin S, Wilson MP, et al. Accuracy of drug store blood pressure monitors: an observational study. Blood Press Monit 2013; 18(6): 339-341.
27. Gonzalvo J, Zillich A. Accuracy of automated community pharmacy-based blood pressure devices. J Am Pharm Assoc 2003; 51(3): 408-411.
28. British Hypertension Society. Blood pressure monitors validated for home use. http://bhsoc.org//index.php?cID=246 (accessed 16 Mar 2016).
29. A'Court C, Stevens R, Sanders S, et al. Type and accuracy of sphygmomanometers in primary care: a cross-sectional observational study. Br J Gen Pract 2011; DOI: 10.3399/bjgp11X593884.
30. de Greeff A, Lorde I, Wilton A, et al. Calibration accuracy of hospital-based non-invasive blood pressure measuring devices. J Hum Hypertens 2010; 24(1): 58-63.
31. Coleman AJ, Steel SD, Ashworth M, et al. Accuracy of the pressure scale of sphygmomanometers in clinical use within primary care. Blood Press Monit 2005; 10(4): 181-188.
32. Amoore JN, Dewar D, Gough K, Padfield PL. Do SpaceLabs ambulatory non-invasive blood pressure recorders measure blood pressure consistently over several years use? Blood Press Monit 2005; 10(1): 51-56.
33. Botomino A, Martina B, Ruf D, et al. White coat effect and white coat hypertension in community pharmacy practice. Blood Press Monit 2005; 10(1): 13-18.
34. Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá Á, Martinez-Martinez F. Comparison of the white-coat effect in community pharmacy versus the physician's office: the Palmera study. Blood Press Monit 2011; 16: 62-66.
35. Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá Á, Martinez-Martinez F. Agreement between community pharmacy, physician's office, and home blood pressure measurement methods: the Palmera study. Am J Hypertens 2012; 25(3): 290-296.
36. Coleman A, Steel S, deGreeff A, Shennan A. Validation of the Lloyds Pharmacy BP11 oscillometric blood pressure monitor according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2010; 15(3): 163-166.
37. Baral-Grant S, Haque MS, Nouwen A, et al. Self-monitoring of blood pressure in hypertension: a UK primary care survey. Int J Hypertens 2012; 2012: 582068.
38. Bostock Y, Hanley J, McGown D, et al. The acceptability to patients and professionals of remote blood pressure monitoring using mobile phones. Prim Health Care Res Dev 2009; 10: 299-308.
39. Department of Health. Pharmacy in England: building on strengths-delivering the future. 2008. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/228858/7341.pdf (accessed 16 Mar 2016).
40. Department of Health. Equity and excellence: liberating the NHS. London: The Stationery Office, 2010.